| 18/02/22 | 14:06:01 | 18 Feb 2022 | | Second Price Monitoring Extn |
| 18/02/22 | 14:00:48 | 18 Feb 2022 | | Price Monitoring Extension |
| 17/02/22 | 09:05:58 | 17 Feb 2022 | | Second Price Monitoring Extn |
| 17/02/22 | 09:00:40 | 17 Feb 2022 | | Price Monitoring Extension |
| 17/02/22 | 07:00:08 | 17 Feb 2022 | | Full Year Trading Update |
| 04/02/22 | 07:00:04 | 4 Feb 2022 | | KOL Investor Event on Iron Deficiency |
| 07/01/22 | 07:00:07 | 7 Jan 2022 | | Investor Presentation |
| 05/01/22 | 07:00:08 | 5 Jan 2022 | | Licence Agreement in Canada for Accrufer® |
| 30/12/21 | 09:06:12 | 30 Dec 2021 | | Second Price Monitoring Extn |
| 30/12/21 | 09:00:55 | 30 Dec 2021 | | Price Monitoring Extension |
| 29/12/21 | 11:05:44 | 29 Dec 2021 | | Second Price Monitoring Extn |
| 29/12/21 | 11:00:40 | 29 Dec 2021 | | Price Monitoring Extension |
| 16/12/21 | 11:05:51 | 16 Dec 2021 | | Second Price Monitoring Extn |
| 16/12/21 | 11:00:49 | 16 Dec 2021 | | Price Monitoring Extension |
| 16/12/21 | 07:00:04 | 16 Dec 2021 | | Patient Access Expands for Accrufer® |
| 30/09/21 | 17:30:05 | 30 Sept 2021 | | Block Listing 6 Monthly Return |
| 27/09/21 | 07:00:07 | 27 Sept 2021 | | Jose A. Menoyo Appointed as Chief Medical Officer |
| 21/09/21 | 07:00:11 | 21 Sept 2021 | | Investor presentation |
| 23/08/21 | 07:00:05 | 23 Aug 2021 | | PDMR Transaction Notification |
| 17/08/21 | 07:00:03 | 17 Aug 2021 | | Half-year Report |
